Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)
Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 07 Jan 2028. Budget: 500,000 USD. The purpose of this Notice of Funding Opportunity (NOFO) is to invite research grant applications (R01) for the development and use of current and emerging molecular imaging methods to gain fundamental insights into cancer inflammation in vivo. The motivation for this initiative is that much of curr…
Opportunity overview
- Project name
- Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)
- Donor
- National Institutes of Health
Key details
- Opportunity start date
- Opportunity end date
- Project location(s)
- United States
- Budget
- 500,000
- Currency
- US Dollar
Summary
Frequently asked questions
What is Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)?
Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 07 Jan 2028. Budget: 500,000 USD. The purpose of this Notice of Funding Opportunity (NOFO) is to invite research grant applications (R01) for the development and use of current and emerging molecular imaging methods to gain fundamental insights into cancer inflammation in vivo. The motivation for this initiative is that much of curr…
Who is funding Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)?
Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed) is funded by National Institutes of Health.
When is the deadline to apply for Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)?
The application deadline is 07 Jan 2028 00:00 (UTC).
Where will the Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed) project take place?
The project location(s) are: United States.
What is the budget for Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)?
The available budget is 500,000 USD.
How can I apply for Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)?
Create a free Contexium account to view the full opportunity details and submit an application via the marketplace.